68GA-DOTATOC PET/CT IMAGES REPRESENT THE CLINICAL CHARACTERISTICS OF PANCREATIC NEUROENDOCRINE TUMORS

被引:0
|
作者
Kim, So Jeong
Cha, Jongtae
Lee, Hee Seung
Chung, Moon Jae
Park, Jeong Youp
Bang, Seungmin
Park, Seung Woo
Song, Si Young
Cho, Arthur
Jo, Jung Hyun
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1198
引用
收藏
页码:S323 / S324
页数:2
相关论文
共 50 条
  • [41] Correlation study between 68Ga-DOTATOC PET/CT metrics and 177Lu-DOTATATE dosimetry for non-pancreatic neuroendocrine tumors
    Texier, J. S.
    Jocmek, M.
    Dierickx, L.
    Vallot, D.
    Brillouet, S.
    Lamesa, C.
    Courbon, F.
    Vija, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 160 - 160
  • [42] Risk stratification in pancreatic neuroendocrine tumours: the role of combined 68Ga-DOTATOC and 18F-FDG PET/CT
    Mapelli, Paola
    Partelli, Stefano
    Salgarello, Matteo
    Muffatti, Francesca
    Rancoita, Paola Maria
    Pasetto, Stefano
    Gianolli, Luigi
    Falconi, Massimo
    Picchio, Maria
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [43] Dual tracer 68Ga-DOTATOC and 18F-FDG PET/CT for risk stratification in pancreatic neuroendocrine neoplasms
    Mapelli, P.
    Salgarello, M.
    Partelli, S.
    Muffatti, F.
    Pasetto, S.
    Rancoita, P.
    Gianolli, L.
    Falconi, M.
    Picchio, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S64 - S65
  • [44] 68Ga-DOTATOC PET/CT in the monitoring of 90Y-DOTATOC treatment
    Versari, Annibale
    Fraternali, Alessandro
    Frasoldati, Andrea
    Carpi, Amalia
    Asti, Mattia
    Filice, Angelina
    Di Paolo, Maria Liberata
    Fioroni, Federica
    Giunta, Francesca
    Calandri, Enrico
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [45] Exceptional increase in somatostatin receptor expression in pancreatic neuroendocrine tumour, visualised with 68Ga-DOTATOC PET
    Marcus Henze
    Jochen Schuhmacher
    Antonia Dimitrakopoulou-Strauss
    Ludwig G. Strauss
    Helmut R. Mäcke
    Michael Eisenhut
    Uwe Haberkorn
    European Journal of Nuclear Medicine and Molecular Imaging, 2004, 31 : 466 - 466
  • [46] Radiochemical purity and patient preparation: Key factors affecting the accuracy of 68Ga-DOTATOC PET/CT imaging in neuroendocrine tumors
    Panagiotidis, Emmanouil
    Andreou, Sotiria
    Vatalis, Anastasios
    Paschali, Anna
    Kalathas, Theodore
    Pipintakou, Aggeliki
    Zoglopitou, Lydia
    Makridou, Anna
    Chatzipavlidiou, Vasiliki
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2024, 27 (03) : 236 - 242
  • [47] Dynamic whole-body 68Ga-DOTATOC PET/CT
    Lodge, Martin
    Rahmim, Arman
    Antoniou, Alexander
    Solnes, Lilja
    Wahl, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [48] 68Ga-DOTATOC Embolus Manifestation and Spontaneous Resolution by PET/CT
    Akram Al-Ibraheem
    Deya’ Aldeen Sweedat
    Farah Anwer
    Feras Istatieh
    Malik E. Juweid
    Nuclear Medicine and Molecular Imaging, 2022, 56 : 208 - 210
  • [49] 68Ga-DOTATOC PET/CT in Thyroid Metastases of Lung Carcinoid
    Leccisotti, Lucia
    Lorusso, Margherita
    Giannetta, Elisa
    Isidori, Andrea M.
    Rufini, Vittoria
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (12) : E492 - E494
  • [50] Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor
    Menda, Yusuf
    O'Dorisio, Thomas M.
    Howe, James R.
    Schultz, Michael
    Dillon, Joseph S.
    Dick, David
    Watkins, G. Leonard
    Ginader, Timothy
    Bushnell, David L.
    Sunderland, John J.
    Zamba, Gideon K. D.
    Graham, Michael
    O'Dorisio, M. Sue
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (07) : 1054 - 1057